Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial

Prostate Cancer and Prostatic Diseases, Published online: 30 May 2023; doi:10.1038/s41391-023-00682-2Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial

Source: Prostate Cancer and Prostatic Diseases - May 30, 2023 Category: Urology & Nephrology Authors: Carsten-Henning Ohlmann Michelle J äschke Peter Jaehnig Susanne Krege J ürgen Gschwend Heidrun Rexer Kerstin Junker Roger Zillmann Christoph R üssel Eva Hellmis Henrik Suttmann Martin Janssen Jan Marin Andreas H übner Michael Mathers Jochen Glei ßner Source Type: research